O36.0133 Maternal care for anti-D [Rh] antibodies, third trimester, fetus 3

Name of the Condition

• Maternal care for anti-D [Rh] antibodies, third trimester, fetus 3
• ICD Code: O36.0133

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has anti-D (Rh) antibodies and is carrying a third fetus. The focus is on managing the risk of hemolytic disease in the fetus or newborn, which can occur if the fetus is Rh-positive. Care includes assessment of antibody levels, fetal monitoring, and planning for potential interventions to prevent or treat complications.

Causes

The presence of anti-D antibodies typically results from prior exposure to Rh-positive blood, such as during a previous pregnancy with an Rh-positive fetus, blood transfusion, or trauma. These antibodies can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to hemolysis.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Trauma or procedures (e.g., amniocentesis) during pregnancy that may cause fetal-maternal bleeding
• Unknown prior sensitization (e.g., from unrecognized fetal-maternal hemorrhage)

Symptoms

• No direct maternal symptoms; the condition is identified through laboratory testing
• Potential fetal complications (e.g., anemia, hydrops fetalis) may develop, but these are not maternal symptoms

Diagnosis

Diagnosis involves testing the mother's blood for anti-D antibodies and determining the Rh status of the fetus. Fetal monitoring may include ultrasound and Doppler studies to assess for signs of anemia or other complications.

Treatment Options

Treatment may include close monitoring of antibody levels, fetal surveillance, and administration of Rh immunoglobulin (RhoGAM) if indicated. In severe cases, interventions such as intrauterine transfusion or early delivery may be necessary.

Prognosis and Follow-Up

With proper management, outcomes for both mother and fetus are generally favorable. Follow-up care involves ongoing monitoring of antibody levels and fetal well-being until delivery.

Complications

Potential complications include hemolytic disease of the fetus or newborn (HDFN), fetal anemia, hydrops fetalis, and preterm birth.

Lifestyle & Prevention

Preventive measures include administration of Rh immunoglobulin (RhoGAM) after sensitizing events to reduce the risk of antibody formation in Rh-negative women.

When to Seek Professional Help

Seek medical attention if there are signs of fetal distress, such as decreased fetal movement, or if there are concerns about the pregnancy.

Tips for Medical Coders

Document the trimester (third) and the number of the fetus (3) as specified in the code. Ensure that the presence of anti-D antibodies and the Rh status of the fetus are clearly documented to support the code assignment.